CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 28 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $147,275 | +3.3% | 250,000 | 0.0% | 0.02% | -4.2% |
| Q1 2023 | $142,625 | -14.5% | 250,000 | 0.0% | 0.02% | -33.3% |
| Q4 2022 | $166,750 | -54.3% | 250,000 | 0.0% | 0.04% | -29.4% |
| Q3 2022 | $365,000 | -76.5% | 250,000 | -50.8% | 0.05% | -76.7% |
| Q1 2022 | $1,550,000 | -21.6% | 508,322 | 0.0% | 0.22% | +0.9% |
| Q4 2021 | $1,977,000 | -26.2% | 508,322 | 0.0% | 0.22% | -3.6% |
| Q3 2021 | $2,679,000 | -11.0% | 508,322 | 0.0% | 0.22% | +10.3% |
| Q2 2021 | $3,009,000 | -16.7% | 508,322 | 0.0% | 0.20% | -26.4% |
| Q1 2021 | $3,614,000 | – | 508,322 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |